What Are Rheumatoid Nodules?

Understanding the Risks and Possible Treatment

In This Article
Table of Contents

If you have rheumatoid arthritis (RA), you may wonder if developing rheumatoid nodules is inevitable. Rheumatoid nodules are firm, non-tender, subcutaneous (under the skin) nodules that tend to appear on fingers and knuckles, elbows, knees, and forearms. They can also form in the eyes, vocal cords, and internal organs, but this is rare. Up to 40% of people with rheumatoid arthritis will eventually develop nodules.


Around 7% of people with rheumatoid arthritis will have nodules when they are first diagnosed. Having nodules at the time of diagnosis is associated with significantly more joint damage down the road as well as a greater risk of systemic complications.

Rheumatoid nodules are more likely to occur in people who have been living with RA for a long time and in those with more severe forms of the disease. Nodules are also more likely to occur in people who have extra-articular disease (meaning RA affecting parts of the body other than just the joints).

Having a high level of rheumatoid factor (RF) in your blood also predisposes you to nodules. RF is a protein called an autoantibody produced by your immune system that can attack healthy tissue in your body; they are responsible for several types of autoimmune diseases.

The risk of developing rheumatoid nodules is higher among people with RA who smoke as well as those who take the drug methotrexate, a common RA medication.

Rheumatoid factor is present in around 80% of people with RA. It also occurs in several other diseases, such as cancers, systemic lupus erythematosus, hepatitis, and some other infections. Some people without any known disorder, particularly older adults, will have RF in their blood as well.

Patients who test positive for an antibody known as anti-cyclic citrullinated peptide (anti-CCP) also have an increased risk of developing nodules. Anti-CCP antibodies are present in over 70% of people who have RA and, unlike RF, are almost always absent in people who do not have the disease.

People with RA who are bedridden are likely to form rheumatoid nodules on pressure points, such as the backs of their elbows, legs, hips, or sacrum. Sometimes rheumatoid nodules may form on the scalp at the back of the head.

Caplan syndrome—which causes nodules to form in the lungs—can occur in people who have rheumatoid arthritis in addition to pneumoconiosis, a lung disease caused by inhaled toxins such as asbestos and coal dust.

While all of these are known causes of nodules, experts still don't know for sure why nodules develop in some people with RA and not in others. It is thought that there may be a genetic component.


Rheumatoid nodules are painless masses of inflammatory tissue, generally measuring between 2 millimeters and 5 centimeters and appearing as a single mass or in clusters (called micro-nodules). They are usually round, occasionally linear, and usually not painful. When multiple nodules form in one location, such as on the fingers or backs of the hands, this is called accelerated nodulosis.

Rheumatoid nodules are typically moveable and have a rubbery feel. Those attached to bones or tendons usually feel hard or firm to the touch. During a flare, the nodules may become painful.

Nodular masses can also occur with gout (called gout tophi), rheumatic fever, xanthomatosis, and sarcoidosis, among other conditions. One distinguishing feature of rheumatoid nodules is that they rarely ulcerate or come through the overlying skin.

Rheumatoid nodules most commonly occur over bony areas and extensor joints. These include:

  • Elbow tips
  • Knuckles
  • Forearms
  • Fingers
  • Knees
  • Backs of heels

Rarely, nodules are not joint-related and may occur in these areas:

  • Eyes
  • Lungs
  • Vocal cords
  • Vulva
  • Gallbladder
  • Heart valves
  • Spine

When nodules occur in these locations, they can be hard to identify or diagnose properly. Nodules can be asymptomatic (as is usually the case with lung nodules, for example) or may overlap with characteristics of other conditions.


On rare occasions, the skin over a nodule will become infected or ulcerated. This tends to occur in areas that are subject to pressure on a regular basis. When nodules form on the backs of heels or bottoms of the feet, they can limit mobility and potentially be debilitating.

Having rheumatoid nodules, especially at the time of diagnosis, indicates a higher risk of developing systemic inflammation (as opposed to it being limited to the joints). This, in turn, can increase the risk of kidney disease, lung complications, heart attack, and stroke, as well as inflammation of the blood vessels, known as vasculitis.


Rheumatoid nodules may disappear over time, or they may get smaller or larger. There is currently no way to predict which nodules will change or go away on their own.

Nodules can be unsightly, but they are only occasionally debilitating, so they aren't usually treated aggressively, if at all. Sometimes, the skin around a nodule can become infected or ulcerated. In these cases, treatment of those complications is necessary.

Treatment with DMARDs or TNF blockers, used for rheumatoid arthritis in general, may or may not eliminate rheumatoid nodules.

Of the currently available drug therapies, Rituxan (rituximab) has been shown to reduce the size of nodules by as much as 50% within 34 to 39 weeks, according to a small study conducted in Germany in 2013.

The surgical removal of nodules is an option, but these tend to recur in as little as a few months after surgery. For this reason, surgery is usually discouraged. The same applies to intranodular injections of steroids which also tend to recur.

If you are concerned about your nodules, talk to your physician about the available treatment options.

Was this page helpful?
Article Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Choi T, Kim HK, Lee DG. Rheumatoid nodule at the scrotum: a rare manifestation of rheumatoid arthritis. J Rheumatol. 2018;45(8):1198-9. doi:10.3899/jrheum.171173

  2. Nyhäll-Wåhlin BM, Turesson C, Jacobsson LT, et al. The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years. Scand J Rheumatol. 2011;40(2):81-7. doi:10.3109/03009742.2010.509103

  3. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD, Tanasescu R. Extra-articular manifestations in rheumatoid arthritisMaedica (Buchar). 2010;5(4):286-91.

  4. Talotta R, Atzeni F, Batticciotto A, Ditto MC, Gerardi MC, Sarzi-Puttini P. Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case seriesJ Med Case Rep. 2018;12(1):154. doi:10.1186/s13256-018-1687-y

  5. Nielsen SF, Bojesen SE, Schnohr P, Nordestgaard BG. Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ. 2012;345:e5244. doi:10.1136/bmj.e5244

  6. Eker YÖ, Pamuk ÖN, Pamuk GE, Dönmez S, Çakır N. The frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: a comparative studyEur J Rheumatol. 2014;1(2):67-71. doi:10.5152/eurjrheumatol.2014.022

  7. Shaw M, Collins BF, Ho LA, Raghu G. Rheumatoid arthritis-associated lung disease. Eur Respir Rev. 2015;24(135):1-16. doi:10.1183/09059180.00008014

  8. Firestein GS, Kelley WN. Kelleys Textbook of Rheumatology. Philadelphia, PA: Elsevier/Saunders; 2013.

  9. Sharma A, Albert D. Dermatological manifestations of rheumatoid arthritis. Rheumatology (Sunnyvale). 2015;5:3. doi:10.4172/2161-1149.1000168

  10. National Rheumatoid Arthritis Society. Rheumatoid nodules. Updated September 16, 2015.

  11. Braun MG, Wagener P. Regression of peripheral and pulmonary rheumatoid nodules under therapy with rituximab. Z Rheumatol. 2013;72(2):166-71. doi:10.1007/s00393-012-1054-0

  12. Omar EK, Adimulam S. Does the key to treat Rheumatoid nodules lie with oncology? Is Cisplatin an option?BMC Musculoskelet Disord. 2013;14(Suppl 1):A5. doi:10.1186/1471-2474-14-S1-A5